Distinguishing Perception from Evidence in Psychiatrists' Attitudes Toward Second-Generation Long-Acting Injectable Antipsychotics [Letter].

IF 3.2 3区医学 Q2 Medicine

Neuropsychiatric Disease and Treatment Pub Date : 2026-07-27 eCollection Date: 2026-01-01 DOI:10.2147/NDT.S638774

Yoshiyo Oguchi

引用次数: 0

查看原文本刊更多论文

精神科医生对第二代长效注射抗精神病药物态度的认知与证据辨析[信]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neuropsychiatric Disease and Treatment CLINICAL NEUROLOGY-PSYCHIATRY

CiteScore

5.10

自引率

3.10%

发文量

328

审稿时长

16 weeks

期刊介绍： An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.